載入...
Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
BACKGROUND: VHL mutation is the most common mutation in clear cell renal cell carcinoma (ccRCC). Here, we developed and validated an immune-related signature to predict the prognosis of ccRCC with VHL mutations. METHODS: VHL mutation status and RNA expression were analysed in the TCGA datasets and o...
Na minha lista:
| 發表在: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7720505/ https://ncbi.nlm.nih.gov/pubmed/33372609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01670-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|